Neurodegenerative Diseases Registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study documents baseline and follow-up information on people with neurodegenerative diseases, including Parkinson disease, MSA, and PSP. Participants undergo standardized clinical assessments, questionnaires, and blood collection at baseline and at 1–2 year follow-ups, with additional eye-movement video recordings as needed. The goal is to improve differentiation among parkinsonian syndromes and track changes in function, cognition, and disease burden over time. Data will be collected across groups using disease-specific scales and common measures, enabling longitudinal analyses while adhering to standard follow-up intervals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age should be between 18-80 years old.

Exclusion Criteria:

* Patients with ongoing central nervous system infection and/or acute stroke or active brain tumor.

Where it's running

• Chinese University of Hong Kong
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Vincent Mok, PhD — Chinese University of Hong Kong
• Study coordinator: Elyia Han, Bachelor
• Email: elyiahan@cuhk.edu.hk
• Phone: +852 2697 5027

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Assessing swallowing function in patients with neurodegenerative diseases

  This study looks at how well people with neurodegenerative diseases, like Parkinson's and Motor Neuron Disease, can swallow and how it affects their quality of life.

  Recruiting at 16 sites Kliniken Beelitz GmbH · Innsbruck, Tyrol and 15 other locations · NCT04706234

• Collecting data on neurodegenerative diseases progression markers

  This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.

  Recruiting IRCCS San Raffaele Roma · Cassino, Frosinone · NCT06596746

• Biobank for studying ALS and Alzheimer's diseases

  This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.

  Recruiting New York Stem Cell Foundation Research Institute · New York, New York · NCT06203106

• Using neuroimaging to improve diagnosis and prognosis of Parkinson's disease and related conditions

  This study is trying to find brain imaging markers that can help doctors better diagnose and predict how Parkinson's disease and similar conditions will progress in patients.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT03872102

• A study on early diagnosis and biomarkers for dementia and related diseases

  This study is testing new ways to spot dementia and related diseases early by looking for specific markers in the brain and body, to help people at high risk and track how well new treatments are working.

  Recruiting at 2 sites Skane University Hospital · Ängelholm and 1 other locations · NCT03174938

• Tributyrin for PSP: a virtual, early-phase study

  This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.

  Recruiting Phase 1/2 University of Michigan · Ann Arbor, Michigan · NCT07863180

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.